Harnessing Proteomics & Deep Learning Approaches to Enable Covalent Drug Discovery
Time: 2:30 pm
day: Conference Day 1
Details:
- Systematic and proteome-wide druggability of proteins in the native setting is synergistically enabled by the combination of Covalency and Mass Spectrometry
- Deep Learning improves deconvolution of Mass Spectrometry-based Proteomics data and boosts the sequence coverage of Covalent Chemoproteomics
- Structural Mass Spectrometry combined with machine learning for improved prediction of ligandability of residues, protein structure, and topology
